Related Experiment Video
Updated: Feb 27, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
An exported protein-interacting complex involved in the trafficking of virulence determinants in Plasmodium-infected
Steven Batinovic1, Emma McHugh1, Scott A Chisholm2
1Department of Biochemistry and Molecular Biology, Bio21 Institute, The University of Melbourne, Parkville, Victoria 3010, Australia.
Abstract:
The malaria parasite, Plasmodium falciparum, displays the P. falciparum erythrocyte membrane protein 1 (PfEMP1) on the surface of infected red blood cells (RBCs). We here examine the physical organization of PfEMP1 trafficking intermediates in infected RBCs and determine interacting partners using an epitope-tagged minimal construct (PfEMP1B). We show that parasitophorous vacuole (PV)-located PfEMP1B interacts with components of the PTEX (Plasmodium Translocon of EXported proteins) as well as a novel protein complex, EPIC (Exported Protein-Interacting Complex). Within the RBC cytoplasm PfEMP1B interacts with components of the Maurer's clefts and the RBC chaperonin complex. We define the EPIC interactome and, using an inducible knockdown approach, show that depletion of one of its components, the parasitophorous vacuolar protein-1 (PV1), results in altered knob morphology, reduced cell rigidity and decreased binding to CD36. Accordingly, we show that deletion of the Plasmodium berghei homologue of PV1 is associated with attenuation of parasite virulence in vivo.
Insights
Malaria parasite protein PfEMP1 trafficking was investigated. We identified novel protein interactions and found that PV1 depletion alters infected red blood cell properties and reduces virulence.
Area of Science:
- Cell Biology
- Parasitology
- Molecular Biology
Background:
- Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is crucial for malaria parasite virulence.
- Understanding PfEMP1 trafficking is key to developing new antimalarial strategies.
Purpose of the Study:
- To investigate the physical organization and interacting partners of PfEMP1 trafficking intermediates.
- To define the EPIC (Exported Protein-Interacting Complex) interactome and its role in PfEMP1 transport.
Main Methods:
- Used an epitope-tagged minimal PfEMP1 construct (PfEMP1B) in infected red blood cells (RBCs).
- Investigated protein interactions within the parasitophorous vacuole (PV) and RBC cytoplasm.
- Employed inducible knockdown of PV1 and deletion studies in Plasmodium berghei.
Main Results:
- Identified interactions of PfEMP1B with PTEX and the novel EPIC complex in the PV.
- Discovered interactions with Maurer's clefts and RBC chaperonins in the cytoplasm.
- Depletion of PV1 led to altered knob morphology, reduced RBC rigidity, and decreased CD36 binding.
- Deletion of the P. berghei PV1 homolog attenuated parasite virulence in vivo.
Conclusions:
- PfEMP1 trafficking involves interactions with PTEX, EPIC, Maurer's clefts, and chaperonins.
- PV1 is essential for PfEMP1 display, RBC modification, and parasite virulence.
Related Concept Videos
Protein Transport to the Inner Chloroplast Membrane
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Translocation Machinery on the ER Membrane
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the...
Intracellular Movement of Viruses and Bacteria
Protein Transport to the Outer Chloroplast Membrane
Two models describe the mechanism of precursor recognition and entry across the outer membrane through the TOC complex. Model 1 suggests the newly synthesized precursor binds to the TOC receptor 159 and forms a complex.

